Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome

Anticancer Research

Volumn 22, Issue 1 A, 2002, Pages 121-128

  Oudard, Stephane ^a   Levalois, Cecile ^a   Andrieu, Jean Marie ^a   Bougaran, Joelle ^a   Validire, Pierre ^a   Thiounn, Nicolas ^a   Poupon, Marie France ^a   Fourme, Emmanuelle ^a   Chevillard, Sylvie ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Apoptosis; Ki67; Multidrug resistance; Renal cell carcinoma

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY CARCINOMA; MALE; MULTIDRUG RESISTANCE; MULTIGENE FAMILY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, RENAL CELL; CELL DIVISION; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION; HUMANS; KI-67 ANTIGEN; KIDNEY NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDINE KINASE;

EID: 0036244343     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Expression of a multidrug-resistance gene in human tumors and tissues
2. Glutathione-related mechanisms in cellular resistance to anticancer drugs
3. Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: Evidence for decreased susceptibility to drug-induced DNA damage and reduced levels of topoisomerase II
4. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
5. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary tumor response and overvall survival
6. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with bax
7. Multiple Bcl-2 family members demonstrate selective dimerization with Bax
8. Prognostic significance of morphologic parameters in renal cell carcinoma
9. TNM staging of renal cell carcinoma: Workgroup No.3
10. Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy
11. Biological and clinical significance of concurrent p53 gene alterations, MDR1 gene expression, and S-phase fraction analyses in breast cancer patients treated with primary chemotherapy or radiotherapy
12. Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance gene
13. MDR1 RNA levels in human renal cell carcinomas: Correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants
14. Expression patterns of multidrug-resistance, multidrug resistance-associated protein, glutathione-S-transferase-π and DNA topoisomerase II genes in renal cell carcinomas and normal kidney
15. Expression of the multidrug resistance gene in human renal cell carcinoma depends on tumor histology, grade and stage
16. Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcomas of childhood
17. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis
18. Is the expression of multidrug resistance gene product a prognostic indicator for the clinical outcome of patients with renal cancer?
19. Immunocytochemical detection of P-glycoprotein: Initial expression correlates with survival in renal cell carcinoma patients
20. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport
21. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines
22. Expression of the multidrug resistance-associated protein gene in human cancers
23. Expression of anionic glutathione S-transferase and p-glycoprotein genes in human tissues and tumors
24. Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues
25. Topoisomerase II: A specific marker for cell proliferation
26. Decreased levels of topoisomerase IIα in human renal cell carcinoma lines resistant to etoposide
27. Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma
28. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal ki-67 antibody labeling
29. Quantitative expression of intratumoral thymidylate synthase predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: Preliminary report from an ongoing trial
30. Unstable methotrexate resistance in human small cell carcinoma associated with double minute chromosomes
31. Bax suppresses tumorigenesis and stimulates apoptosis in vivo
32. Apoptosis supressing protein Bcl-2 is expressd in well differentiated breast carcinoma with favorable prognosis
33. Expression and prognostic significance of bcl-2 in ovarian tumors
34. Frequent expression of bcl-2 in renal cell carcinoma carrying wild-type p 53
35. p53, bcl-2 and Bax expression in renal cell carcinoma
36. Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma
37. Expression of p53 and bcl-2 in primary locally confined renal cell carcinomas: No evidence for prognostic significance
38. Bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs